Hologic’s recent trading activity
On September 17, Hologic (HOLX) ended the day at $39.53. The stock was down ~0.3% from its previous trading day’s closing price of $39.64. The stock has recuperated some of the losses it saw during the first half of fiscal 2018. It witnessed a declining trend after reporting its 52-week high of $45.09 on January 9, 2018.
Currently, HOLX stock is trading lower than its 50-day moving average of $39.80 but higher than its 200-day moving average of $39.16. During the last one week, HOLX stock was up ~2%, while the stock’s one-month gains stand at ~3.1%. However, the stock has declined by ~1.7% over the last three months. Year-to-date, HOLX stock has declined ~7.5%.
Over the last one year, HOLX stock is up ~5.8%. Peers Abbott Laboratories (ABT), Thermo Fisher Scientific (TMO), and Varian Medical Systems (VAR) registered returns of 30%, 24.3%, and 3%, respectively, over the same period.
Recent developments that have impacted HOLX stock
On September 12, Hologic cut its Cynosure unit revenue forecast for fiscal 2018. The event triggered a decline of ~4.8% in HOLX stock prices during pre-market trading on September 13. However, during the day, the stock recovered the losses and closed at a gain of ~1.1% as compared to its closing price on the previous trading day. We’ll discuss the event in more detail in the next article.
On August 13, the day the company announced the recall and suspension of marketing and distribution of its Vitalia handpieces and probes, HOLX stock declined ~4%. The stock’s trading was halted after the news. However, Hologic registered strong Q3 2018 earnings results on July 31, which triggered a rise of ~1.3% in HOLX stock on the following day.
Be sure to check out all the data we’ve added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data, as well as dividend information. Take a look!